![Christopher D. Hutchins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher D. Hutchins
Keine laufenden Positionen mehr
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Enrique Lores | M | 58 | 35 Jahre | |
Heidi Fields | F | 69 | 24 Jahre | |
Dominique Grau | M | 64 | 25 Jahre | |
Timothy Brown | M | 57 | 31 Jahre | |
Rodney Gonsalves | M | 58 | 25 Jahre | |
Stacy Wolff | F | - | 27 Jahre | |
Stephanie Dismore | F | 51 | 25 Jahre | |
Kobi Elbaz | M | - | 28 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Didier Hirsch | M | 72 | 29 Jahre | |
William Sullivan | M | 74 | 16 Jahre | |
Edward Barnholt | M | 81 | 39 Jahre | |
Lewis E. Platt | M | 83 | 33 Jahre | |
Carly Fiorina | F | 69 | 6 Jahre | |
Catherine Lesjak | F | 65 | 33 Jahre | |
Stacey Stevens | F | 56 |
Philips Medical Systems
![]() Philips Medical Systems Medical SpecialtiesHealth Technology Philips Healthcare is engaged in the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, and patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlands, which is a global company in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions. It classifies its business activities into six areas, namely, Home Healthcare, Professional Healthcare, Imaging Systems, Clinical Care Systems, Healthcare Informatics and Customer Services. The company holds manufacturing facilities in The Netherlands, Germany, the US, Finland, Israel and Brazil. Philips Healthcare is headquartered in Massachusetts, the US. | 5 Jahre |
Jon Fong | M | - | 14 Jahre | |
D. Craig Nordlund | M | 74 | 22 Jahre | |
Neil Dougherty | M | 55 | - | |
Richard A. Burdsall | M | - | 9 Jahre | |
James Cullen | M | 81 | - | |
James T. Murrin | M | 63 | - | |
Daryl Raiford | M | 61 | 5 Jahre | |
Richard T. Spencer | M | 87 |
Viacor, Inc.
![]() Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | 4 Jahre |
Michael B. Cox | M | - | - | |
David Packard | M | - | 57 Jahre | |
Randy Dobbs | M | 73 |
Philips Medical Systems
![]() Philips Medical Systems Medical SpecialtiesHealth Technology Philips Healthcare is engaged in the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, and patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlands, which is a global company in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions. It classifies its business activities into six areas, namely, Home Healthcare, Professional Healthcare, Imaging Systems, Clinical Care Systems, Healthcare Informatics and Customer Services. The company holds manufacturing facilities in The Netherlands, Germany, the US, Finland, Israel and Brazil. Philips Healthcare is headquartered in Massachusetts, the US. | 2 Jahre |
James V. Russo | M | - | 1 Jahre | |
William R. Hewlett | M | - | 62 Jahre | |
Katharine M. Stohlman | F | - |
Viacor, Inc.
![]() Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | 27 Jahre |
Jonathan M. Rourke | M | - |
Viacor, Inc.
![]() Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | 19 Jahre |
Gregory Lambrecht | M | - |
Viacor, Inc.
![]() Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | - |
Charles N. Charnas | M | 65 | - | |
Julie Ione Morris | F | - | 17 Jahre | |
Hilliard Terry | M | 54 | 13 Jahre | |
Martin Scott | M | 68 | 24 Jahre | |
Rick Ellis | M | - |
Philips Medical Systems
![]() Philips Medical Systems Medical SpecialtiesHealth Technology Philips Healthcare is engaged in the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, and patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlands, which is a global company in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions. It classifies its business activities into six areas, namely, Home Healthcare, Professional Healthcare, Imaging Systems, Clinical Care Systems, Healthcare Informatics and Customer Services. The company holds manufacturing facilities in The Netherlands, Germany, the US, Finland, Israel and Brazil. Philips Healthcare is headquartered in Massachusetts, the US. | 20 Jahre |
Kenneth John Frier | M | - | - | |
Scott M. Weisenhoff | M | - |
Philips Medical Systems
![]() Philips Medical Systems Medical SpecialtiesHealth Technology Philips Healthcare is engaged in the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, and patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlands, which is a global company in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions. It classifies its business activities into six areas, namely, Home Healthcare, Professional Healthcare, Imaging Systems, Clinical Care Systems, Healthcare Informatics and Customer Services. The company holds manufacturing facilities in The Netherlands, Germany, the US, Finland, Israel and Brazil. Philips Healthcare is headquartered in Massachusetts, the US. | 4 Jahre |
Paul T. Porrini | M | 62 | 11 Jahre | |
Thomas Lawson | M | - | - | |
David M. Lawrence | M | 83 | 15 Jahre | |
Jessica Denecour | F | 62 | 22 Jahre | |
Frank Ostojic | M | - | - | |
Gregory Matz | M | 64 | 26 Jahre | |
Kristin Giffin | F | - | - | |
Lynne J. Camp | F | 66 | 10 Jahre | |
Eric P. Buatois | M | 65 | 14 Jahre | |
William T. Hayes | M | - |
Viacor, Inc.
![]() Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | 10 Jahre |
Richard D. Kniss | M | 82 | 6 Jahre | |
John A. Young | M | 91 | 34 Jahre | |
Pascal Rondé | M | 62 | 6 Jahre | |
John C. Boutsikaris | M | 76 | 11 Jahre | |
Robert John Herbold | M | 81 | - | |
Thomas A. Saponas | M | 74 | 31 Jahre | |
Jeffrey H. Barnes | M | 62 | 2 Jahre | |
Gilles Bouchard | M | 63 | 20 Jahre | |
Dorothy Hayes | F | 73 | 14 Jahre | |
Jean Nye | F | 71 | 34 Jahre | |
Neal J. Carney | M | 68 | 6 Jahre | |
Robert R. Walker | M | 72 | 8 Jahre | |
Juan B. Otero | M | 60 | 2 Jahre | |
Adrian Dillon | M | 70 | 9 Jahre | |
A. Barry Rand | M | 79 | 15 Jahre | |
Michael Glen Dallas | M | 55 | - | |
Kevin M. Harris | M | 61 | 2 Jahre | |
Christopher Mierzwa | M | - | - | |
Allison Johnson | F | 62 | 6 Jahre | |
Mike Millard, MBA | - | - | 2 Jahre | |
John Page | M | - | - | |
Jan Zadak | M | 59 | - | |
Melanie Tansey | F | - | - | |
Jeffrey D. Thiemann | M | - | 18 Jahre | |
Thomas Kenny | M | - | 16 Jahre | |
Edward Rockwell | M | 56 | 11 Jahre | |
Jeffrey Clarke | M | 62 | 1 Jahre | |
C. Alexis Keene | F | - | 7 Jahre | |
Mary Smith | F | 64 | 10 Jahre | |
Bee Choon Yeo | M | 65 | 17 Jahre | |
John R. Busch | M | - | 17 Jahre | |
Gene Zamiska | M | 63 | 18 Jahre | |
John L. Doyle | M | 92 | 36 Jahre | |
Geun-Myeong Lee | M | 67 | 15 Jahre | |
Robert Knowling | M | 68 | 5 Jahre | |
Glenn Osaka | M | 68 | 19 Jahre | |
Jef T. Graham | M | 68 | 15 Jahre | |
Tom Uhlman | M | 75 | 12 Jahre | |
J. Adriaan Theron | M | - | 12 Jahre | |
George A. Keyworth | M | 84 | 20 Jahre | |
David Booth | M | - | - | |
Richard C. Alberding | M | 93 | 33 Jahre | |
Marc Vanden Bossche | M | - | - | |
Bradley R. Anderson | M | 65 | - | |
Joel W. Achramowicz | M | - | 10 Jahre | |
Philip M. Condit | M | - | 6 Jahre | |
Ron Eller | M | 63 | 14 Jahre | |
Atul Bhatnagar | M | 66 | 15 Jahre | |
Paul Weiskopf | M | - | 5 Jahre | |
Kathy Smith Boyd | F | 69 | 15 Jahre | |
Jay McClatchey | M | - | 5 Jahre | |
Bertrand Chevalier | M | 47 | 15 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Mauritius | 83 | 83,00% |
Vereinigte Staaten | 40 | 40,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Christopher D. Hutchins
- Persönliches Netzwerk